Advisory Services Network’s Cognition Therapeutics CGTX Stock Holding History

Advisory Services Network’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,500	Closed	-$1.9K	–	2585
2026 Q1	$1.9K	Buy	+2,500	New	+$2.91K	﹤0.01%	4151
2025 Q4	–	Sell	-2,500	Closed	-$3.38K	–	2229
2025 Q3	$3.38K	Buy	+2,500	New	+$3.41K	﹤0.01%	3662
2024 Q1	–	Sell	-2,500	Closed	-$4.63K	–	1823
2023 Q4	$4.63K	Buy	+2,500	New	+$3.31K	﹤0.01%	3140

Other funds holding CGTX

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HCM

Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Advisory Services Network's CGTX Position: Q2 2026 in Review

Advisory Services Network sold out of Cognition Therapeutics (CGTX) in Q2 2026, closing a stake of 2,500 shares — an estimated $1.9K sold.

Advisory Services Network first reported a position in CGTX in Q4 2023 and held it in 3 quarters. The position peaked at $4.63K in Q4 2023. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

Advisory Services Network reported no remaining Cognition Therapeutics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 2,500 Cognition Therapeutics shares in Q2 2026, an estimated $1.9K.
Advisory Services Network first reported a position in Cognition Therapeutics in Q4 2023 and held it in 3 quarters.
Advisory Services Network's Cognition Therapeutics position peaked at $4.63K in Q4 2023.
66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.